APP and Alzheimer disease: Enzyme inhibition – a functional pharmacological depletion in AD therapeutics: We apply the deletion heuristic to interpret the effects of drug-induced inhibition of enzyme function observed in clinical trials of AD, particularly with inhibitors of β-secretase, the enzyme responsible for producing Aβ42 from its precursor, amyloid precursor protein.